Deep RNA-seq of male and female murine sensory neuron subtypes after nerve injury
- PMID: 37318015
- PMCID: PMC10502896
- DOI: 10.1097/j.pain.0000000000002934
Deep RNA-seq of male and female murine sensory neuron subtypes after nerve injury
Abstract
Dorsal root ganglia (DRG) neurons have been well described for their role in driving both acute and chronic pain. Although nerve injury is known to cause transcriptional dysregulation, how this differs across neuronal subtypes and the impact of sex is unclear. Here, we study the deep transcriptional profiles of multiple murine DRG populations in early and late pain states while considering sex. We have exploited currently available transgenics to label numerous subpopulations for fluorescent-activated cell sorting and subsequent transcriptomic analysis. Using bulk tissue samples, we are able to circumvent the issues of low transcript coverage and drop-outs seen with single-cell data sets. This increases our power to detect novel and even subtle changes in gene expression within neuronal subtypes and discuss sexual dimorphism at the neuronal subtype level. We have curated this resource into an accessible database for other researchers ( https://livedataoxford.shinyapps.io/drg-directory/ ). We see both stereotyped and unique subtype signatures in injured states after nerve injury at both an early and late timepoint. Although all populations contribute to a general injury signature, subtype enrichment changes can also be seen. Within populations, there is not a strong intersection of sex and injury, but previously unknown sex differences in naïve states-particularly in Aβ-RA + Aδ-low threshold mechanoreceptors-still contribute to differences in injured neurons.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.
Conflict of interest statement
The authors declare no conflicts of interest relevant to this article. More broadly, D. L. Bennett has acted as a consultant on behalf of Oxford Innovation for Amgen, Biointervene, Bristows, LatigoBio, GSK, Ionis, Lilly, Olipass, Orion, Regeneron, and Theranexus over the past 2 years. He has received research funding from Lilly and AstraZeneca. He has received an industrial partnership grant from the BBSRC and AstraZeneca.
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Figures
Comment in
-
Uncovering subtypes of injured nerve cells.Pain. 2023 Oct 1;164(10):2135-2136. doi: 10.1097/j.pain.0000000000002935. Epub 2023 Jun 6. Pain. 2023. PMID: 37278624 No abstract available.
References
-
- Andrews S. FastQC: a quality control tool for high throughput sequence data. 2010. Available at: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. Accessed November 15, 2021.
-
- Attal N, Perrot S, Fermanian J, Bouhassira D. The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 questionnaire. J Pain 2011;12:1080–7. - PubMed
-
- Bailey AL, Ribeiro-Da-Silva A. Transient loss of terminals from non-peptidergic nociceptive fibers in the substantia gelatinosa of spinal cord following chronic constriction injury of the sciatic nerve. Neuroscience 2006;138:675–90. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
